Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE: follitropin alfa
DATE: 16/02/2015
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.
PRIVACY POLICY
SUBSCRIBE
